Adhesive composition
US-12104092-B2 · Oct 1, 2024 · US
Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D223/22 |
| Official title | Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines |
| Display label | Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines |
| Total patents | 35 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is growing.
| Year | Patents |
|---|---|
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 8 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substituted dibenzo[b, f]azepines as proteasome activators
US-12060337-B2 · Aug 13, 2024 · US
Adhesive composition
US-2024002705-A1 · Jan 4, 2024 · US
Adhesive composition
US-11795353-B2 · Oct 24, 2023 · US
Lipoxygenase inhibitors
US-2023174485-A1 · Jun 8, 2023 · US
Small molecule enhancement of 20s proteasome activity targets intrinsically disordered proteins
US-2023002335-A1 · Jan 5, 2023 · US
Substituted phenothiazines as proteasome activators
US-11358942-B2 · Jun 14, 2022 · US
Adhesive composition
US-2021284879-A1 · Sep 16, 2021 · US
Compound and organic light-emitting device including the same
US-11114622-B2 · Sep 7, 2021 · US
Small molecule proteasome activators and uses thereof
US-2020165216-A1 · May 28, 2020 · US
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
US-10639313-B2 · May 5, 2020 · US
Compound for inhibition of delta-5-desaturase (d5d) and treatment of cancer and inflammation
US-2019070193-A1 · Mar 7, 2019 · US
Materials for electronic devices
US-2019002417-A1 · Jan 3, 2019 · US
Novel crystalline form of eslicarbazepine
US-2018127376-A1 · May 10, 2018 · US
Biocatalytic process for preparing eslicarbazepine and analogs thereof
US-9963683-B2 · May 8, 2018 · US
Selective inhibitors of constitutive androstane receptor
US-9908890-B2 · Mar 6, 2018 · US
Blue fluorescent emitters
US-2018016493-A1 · Jan 18, 2018 · US
Compound, light emitting material, and organic light emitting device
US-9818955-B2 · Nov 14, 2017 · US
Condensed-cyclic compound and organic light-emitting device including the same
US-9793496-B2 · Oct 17, 2017 · US
Organic light emitting display device
US-9755161-B2 · Sep 5, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D223/22?
- CPC C07D223/22 is the Cooperative Patent Classification code for “Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines.”
- How many patents are filed under CPC C07D223/22 (Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines)?
- Our database includes 35 publications tagged with this CPC code.
- Is patent activity under CPC C07D223/22 growing?
- Publication counts under this code: 3 in 2023 vs 3 in 2024 (latest complete years).